サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519356

ドラッグデリバリー市場レポート：投与経路、用途、エンドユーザー、地域別、2024年～2032年

Pharmaceutical Drug Delivery Market Report by Route of Administration, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.12円
ドラッグデリバリー市場レポート：投与経路、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のドラッグデリバリー市場規模は、2023年に1兆3,976億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに2兆1,571億米ドルに達し、2024年から2032年の間に4.8%の成長率（CAGR）を示すと予測しています。ターゲットを絞った効率的なドラッグデリバリーシステムに対する需要の高まり、ドラッグデリバリーのイノベーションを促進する個別化医療への注目の高まり、ナノテクノロジーにおける数々の進歩は、ドラッグデリバリー市場のシェアを押し上げる主な要因の一部です。

ドラッグデリバリー市場の分析：

主な市場促進要因：慢性疾患の増加は標的治療への需要を増大させ、それが市場成長の触媒となっています。さらに、患者固有の遺伝子プロファイルにより、患者に合わせた薬物投与方法が必要となるため、個別化薬物療法のニーズが高まっていることも、市場成長に寄与しています。

主要市場動向：正確なドラッグデリバリー機構を促進し、制御放出とより良いバイオアベイラビリティを可能にするナノテクノロジーとバイオマテリアルの数多くの進歩は、市場成長にプラスの影響を与えています。さらに、高齢患者特有のニーズに対応できるユーザーフレンドリーなドラッグデリバリーシステムの採用が増加していることも、市場成長を促進する重要な動向となっています。

地域情勢別：報告書によると、北米は強固なヘルスケアインフラ、強力な研究開発（R&D）能力を有し、慢性疾患の有病率が高いことから、世界市場で最大の市場シェアを占めています。

競合情勢：ドラッグデリバリー市場の主要企業としては、AbbVie Inc.、Amgen Inc.、AstraZeneca plc、Becton Dickinson and Company、Eli Lilly and Company、GSK plc、Johnson &Johnson、Merck KGaA、Novartis AG、Pfizer Inc.、Sanofi S.A.などが挙げられます。

課題と機会：世界なドラッグデリバリー市場における課題には、規制上のハードル、複雑な製造プロセス、継続的なイノベーションの必要性などがあります。ドラッグデリバリー市場最近のビジネスチャンスとしては、慢性疾患の蔓延、標的を絞った制御されたドラッグデリバリーシステムに対する需要の高まり、ナノテクノロジーや生物製剤の進歩などが挙げられます。

ドラッグデリバリー市場傾向：

標的療法に対する需要の高まり

標的治療薬に対する需要の高まりは、ドラッグデリバリー市場の重要な 促進要因です。従来の全身薬物投与はしばしば標的外作用や副作用を引き起こすため、標的治療やドラッグデリバリーの必要性が高まっています。さらに、COVID-19のような生命を脅かすさまざまな感染症の流行が拡大していることも、メーカーに効果的なドラッグデリバリー機器や技術の導入を促しています。このことは、今後数年間のドラッグデリバリー市場の成長に大きく寄与すると予想されます。例えば、2022年2月、Glenmark Pharmaceuticals Limitedは、病気の進行リスクが高い成人COVID-19患者の治療のために、FabiSprayと呼ばれる一酸化窒素点鼻スプレーをインドで発売しました。この他、2020年7月にFrontiers誌に掲載された論文では、糖尿病治療において、薬剤の性質に応じた適切なデリバリーシステムと完全な治療戦略を開発する必要があると述べられています。出典によると、ドラッグデリバリーデバイスは、糖尿病治療の様々な面で大きな可能性を示しています。ドラッグデリバリーは、薬物の安定性を高め、生物学的障壁を克服してバイオアベイラビリティを向上させ、自然なインスリンデリバリーを模倣するスマートな自動化システムとして機能し、低血糖のリスクを低減します。

急速な技術進歩

ドラッグデリバリーデバイスや技術をより患者にやさしく、利用しやすく、正確にするための継続的な技術進歩が、世界のドラッグデリバリー市場の成長をさらに促進しています。これに加えて、様々な主要市場プレーヤーが先進的ドラッグデリバリーデバイスの開発と技術革新に幅広く投資しています。例えば、2021年5月、Phillips-Medisize社はAria Smart Autoinjectorプラットフォームを発売し、製薬業界の革新、差別化、持続可能性を解き放った。このデバイスは、様々な製剤や粘度に対応するモジュラー式ドラッグデリバリープラットフォームや、スマートフォン、タブレット、モバイルアプリとの接続を可能にするブルートゥース内蔵などの先進技術を特徴としています。同様に2021年6月、ロシュは湿性加齢黄斑変性患者を頻繁な眼球注射の必要性から解放するため、ドラッグデリバリーインプラントであるラニビズマブ入りポートデリバリーシステム（PDS）を開発しました。このような技術革新や技術進歩は、今後数年間のドラッグデリバリー市場の収益を促進すると予想されます。

慢性疾患の有病率の増加

世界中で様々な慢性疾患の患者が増加しており、医薬品や薬剤の需要が高まっています。世界保健機関（WHO）によると、慢性疾患は世界の死因のトップです。虚血性心疾患だけでも、2019年には約889万人が死亡しています。さらに、世界中でがん、呼吸器疾患、糖尿病患者の有病率が増加していることが、ドラッグデリバリーデバイスの採用をさらに促進しています。国際がん研究機関2020が発表したデータによると、世界全体では5人に1人が一生の間にがんを発症し、男性の8人に1人、女性の11人に1人が死亡しています。乳がん、大腸がん、肺がん、子宮頸がん、甲状腺がんは女性に多いです。一方、男性に多いのは肺がんと前立腺がんで、男性のがん全体の3分の1近くを占める。さらに、インド国立衛生研究所が発表した報告書「慢性疾患の有病率と潜在的決定要因（2022年）」によると、インドの高齢者人口の約21％が少なくとも1つの慢性疾患に罹患していると報告されています。慢性疾患の症例の増加は、ドラッグデリバリー市場の需要を強化すると予測されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のドラッグデリバリー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：投与経路別

  • 経口ドラッグデリバリー
    • 市場動向
    • 市場予測
  • ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 局所ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 眼科ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 肺へのドラッグデリバリー
    • 市場動向
    • 市場予測
  • 埋め込みドラッグデリバリー
    • 市場動向
    • 市場予測
  • 経粘膜ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 鼻腔内ドラッグデリバリー
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 感染症
    • 市場動向
    • 市場予測
  • がん
    • 市場動向
    • 市場予測
  • 心血管疾患
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • 呼吸器疾患
    • 市場動向
    • 市場予測
  • 中枢神経系疾患
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • ホームケア設定
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2023
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2023
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players
目次
Product Code: SR112024A5796

The global pharmaceutical drug delivery market size reached US$ 1,397.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,157.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032. The rising demand for targeted and efficient drug delivery systems, increasing focus on personalized medicine fostering drug delivery innovations, and numerous advancements in nanotechnology are some of the major factors propelling the pharmaceutical drug delivery market share.

Pharmaceutical Drug Delivery Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is augmenting the demand for targeted therapies, which in turn is catalyzing the market growth. Furthermore, the rising need for personalized medication as unique genetic profiles of patients require tailored drug administration methods is also contributing to the market growth.

Key Market Trends: Numerous advancements in nanotechnology and biomaterials that facilitate precise drug delivery mechanisms, allowing for controlled release and better bioavailability, are positively influencing market growth. Moreover, the rising adoption of user-friendly drug delivery systems that can cater to the specific needs of elderly patients is also acting as another significant trend, driving the market growth.

Geographical Landscape: According to the report, North America accounted for the largest market share in the global market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases.

Competitive Landscape: Some of the leading pharmaceutical drug delivery market companies are AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A., among many others.

Challenges and Opportunities: Challenges in the global pharmaceutical drug delivery market include regulatory hurdles, complex manufacturing processes, and the need for continuous innovation. Pharmaceutical drug delivery market recent opportunities include increasing prevalence of chronic diseases, growing demand for targeted and controlled drug delivery systems, and advancements in nanotechnology and biologics.

Pharmaceutical Drug Delivery Market Trends:

Rising Demand for Targeted Therapies

The escalating demand for targeted therapies is a significant driver in the pharmaceutical drug delivery market. Traditional systemic drug administration often results in off-target effects and adverse reactions, which augment the need for targeted therapies and drug deliveries. Moreover, the growing prevalence of various life-threatening infections, such as COVID-19, is also prompting manufacturers to introduce effective drug-delivery devices and techniques. This is anticipated to significantly contribute to the pharmaceutical drug delivery market growth in the coming years. For instance, in February 2022, Glenmark Pharmaceuticals Limited launched a nitric oxide nasal spray called FabiSpray in India for the treatment of adult patients with COVID-19 who had a high risk of progression of the disease. Besides this, the article published by Frontiers in July 2020 mentioned that it is necessary to develop appropriate delivery systems and complete therapy strategies according to the nature of drugs in treating diabetes mellitus. As per the source, drug-delivery devices have shown significant potential in various aspects of diabetes treatment. They enhance the stability of drugs, overcome biological barriers to increase bioavailability, and act as a smart, automated system to mimic natural insulin delivery, reducing the risk of hypoglycemia.

Rapid Technological Advancements

Ongoing technological advancements in drug delivery devices and techniques to make them more patient-friendly, accessible, and accurate are further catalyzing the growth of the global pharmaceutical drug delivery market. In addition to this, various key market players are extensively investing in the development and innovation of advanced drug-delivery devices. For instance, in May 2021, Phillips-Medisize launched its Aria Smart Autoinjector platform, which unlocked innovation, differentiation, and sustainability in the pharmaceutical industry. This device features advanced technologies such as a modular drug delivery platform that supports a variety of drug formulations and viscosities and has built-in Bluetooth, which enables connectivity to smartphones, tablets, and mobile apps. Similarly, in June 2021, Roche developed a Port Delivery System with ranibizumab (PDS), a drug delivery implant, to free patients with wet age-related macular degeneration from the need to undergo frequent eye injections. Such innovations and technological advancements are anticipated to propel the pharmaceutical drug delivery market revenue in the coming years.

Increasing Prevalence of Chronic Diseases

The rising cases of various chronic ailments across the world are augmenting the demand for medicines and drugs. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Ischemic heart disease alone was responsible for about 8.89 million deaths in 2019. Moreover, the increasing prevalence of cancer, respiratory disease, and diabetic patients across the world is further promoting the adoption of drug delivery devices. According to the data published by the International Agency for Research on Cancer 2020, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die. Breast, colorectal, lung, cervical, and thyroid cancers are common among women. Whereas lung and prostate cancer are the most common among men, accounting for nearly one-third of all male cancers. Furthermore, according to a report published by the National Institute of Health, India, on Prevalence and Potential Determinants of Chronic Diseases, 2022, about 21% of the elderly population in India reportedly have at least one chronic disease. The escalating cases of chronic ailments are projected to bolster the pharmaceutical drug delivery market demand.

Global Pharmaceutical Drug Delivery Industry Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on route of administration, application, and end user.

Breakup by Route of Administration:

Oral Drug Delivery

Injectable Drug Delivery

Topical Drug Delivery

Ocular Drug Delivery

Pulmonary Drug Delivery

Implantable Drug Delivery

Transmucosal Drug Delivery

Nasal Drug Delivery

Oral drug delivery represents the most popular route of administration

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, injectable, topical drug, ocular, pulmonary, implantable, transmucosal, and nasal drug deliveries. According to the report, oral drug delivery represented the largest segment.

Pharmaceutical drug delivery market forecast indicates that oral drug delivery is a prominent route of administration where pharmaceutical compounds are ingested through the mouth and absorbed in the gastrointestinal tract. Oral medications are convenient to administer, making it a preferred choice for various medications. Moreover, the rise in R&D activities and product launches are likely to positively impact the pharmaceutical drug delivery market outlook. For instance, in June 2021, Shilpa Medicare Ltd. launched Molshil, a pediatric dose of paracetamol oral thin film, in India. Furthermore, according to the WHO, in 2021, approximately 275 million people used medications (drugs) at least once. Among them, approximately 62 million people used opioids.

Breakup by Application:

Infectious Diseases

Cancer

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Central Nervous System Disorders

Autoimmune Diseases

Others

Infectious diseases account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and others. According to the report, infectious diseases accounted for the largest market share.

Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites, which can spread from person to person or through contaminated objects. As per the pharmaceutical drug delivery market report by IMARC, the rising prevalence of infectious diseases poses significant global health challenges, necessitating effective treatment strategies. For instance, according to an article by Frontiers in February 2022, non-typhoidal Salmonella, a common cause of bacterial enteritis in humans, causes almost 93.8 million cases of gastroenteritis globally each year.

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Home Care Settings

Diagnostic Centers

Others

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, home care settings, diagnostic centers, and others.

As per the pharmaceutical drug delivery market overview by IMARC, hospitals hold a significant share in the global market. Hospitals as primary care providers utilize a variety of drug delivery methods to ensure effective treatment for diverse patient needs. Ambulatory Surgery Centers demand specialized drug delivery techniques for perioperative care and pain management. Home Care Settings require user-friendly delivery systems for patient self-administration, promoting adherence and comfort. Diagnostic Centers rely on targeted drug delivery to enhance imaging and therapeutic interventions.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the pharmaceutical drug delivery market statistics by IMARC, North America held the biggest share in the market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases. For instance, according to the American Cancer Society's 2022 report, approximately 1.9 million new cancer cases were diagnosed in 2022 in the United States. Besides this, the presence of leading manufacturers in the region, along with the introduction of new products, is also bolstering the growth of the market in North America. For instance, in February 2022, the United States FDA approved the generic Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility and other episodes associated with advanced Parkinson's disease.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Becton Dickinson and Company

Eli Lilly and Company

GSK plc

Johnson & Johnson

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi S.A.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Pharmaceutical Drug Delivery Market Recent Developments

January 2024: Berry Global Healthcare, a patient-centered package design company, showcased its latest range of standard and bespoke pharmaceutical packaging solutions at Pharmapack 2024. The exhibition witnessed the launch of the BerryHaler, an all-plastic, dual chamber, dry powder inhaler (DPI) designed to deliver combination drugs and separately store two medications for subsequent simultaneous inhalation.

October 2023: Victrex plc, a pioneer in the development of PEEK biomaterial solutions launched a new product grade developed exclusively for Drug Delivery and Pharmaceutical Contact applications. VICTREX PC101 meets the highest levels of Industry biocompatibility certification for USP Class VI and also meets industry standards such as USP 661 for use in non-implantable pharmaceutical contact applications.

July 2023: Viatris Inc., a global healthcare company, and Kindeva Drug Delivery L.P. announced the launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort. It comes with an Abbreviated New Drug Application (ANDA) and is approved by the U.S. Food and Drug Administration (FDA).

Key Questions Answered in This Report:

  • How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
  • What are the key regional markets?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical drug delivery market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials